Sujia Wu

1.4k total citations
62 papers, 1.1k citations indexed

About

Sujia Wu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Rheumatology. According to data from OpenAlex, Sujia Wu has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 21 papers in Molecular Biology and 19 papers in Rheumatology. Recurrent topics in Sujia Wu's work include Sarcoma Diagnosis and Treatment (34 papers), Bone Tumor Diagnosis and Treatments (19 papers) and MicroRNA in disease regulation (9 papers). Sujia Wu is often cited by papers focused on Sarcoma Diagnosis and Treatment (34 papers), Bone Tumor Diagnosis and Treatments (19 papers) and MicroRNA in disease regulation (9 papers). Sujia Wu collaborates with scholars based in China, Belgium and Netherlands. Sujia Wu's co-authors include Xin Shi, Guangxin Zhou, Junfeng Zhang, Jianning Zhao, Xiuchun Yu, Xing Zhou, Xiaozhou Liu, Zhaoming Ye, Chengjun Li and Jiangning Chen and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Sujia Wu

61 papers receiving 1.0k citations

Peers

Sujia Wu

PRM

RHEUM

ONCOL

Sílvia Regina Caminada de Toledo Brazil

Chunlai Lu China

Jianqiang Wu United States

Raul Perret France

Emanuela Boštjančič Slovenia

L W Chung United States

Lior Zilberberg United States

Kou Kayamori Japan

Weike Si China

Xin‐Zi Chi South Korea

Sílvia Regina Caminada de Toledo Brazil

Sujia Wu

654 ×1.3

287 ×0.8

186 ×0.6

PRM

59 ×0.3

RHEUM

290 ×1.8

ONCOL

Citations per year, relative to Sujia Wu Sujia Wu (= 1×) peers Sílvia Regina Caminada de Toledo

Countries citing papers authored by Sujia Wu

Since Specialization

Citations

This map shows the geographic impact of Sujia Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sujia Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sujia Wu more than expected).

Fields of papers citing papers by Sujia Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sujia Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sujia Wu. The network helps show where Sujia Wu may publish in the future.

Co-authorship network of co-authors of Sujia Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Sujia Wu. A scholar is included among the top collaborators of Sujia Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sujia Wu. Sujia Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xiaolu, Shoufeng Wang, Jun Chen, et al.. (2024). Neo-adjuvant radiation and intratumoral immunotherapy followed by surgery- NARIS trial for extremity soft tissue sarcoma. Future Oncology. 20(30). 2233–2240.

Xie, Lu, Jie Xu, Wei Guo, et al.. (2021). Management of Apatinib-Related Adverse Events in Patients With Advanced Osteosarcoma From Four Prospective Trials: Chinese Sarcoma Study Group Experience. Frontiers in Oncology. 11. 696865–696865. 6 indexed citations

Zheng, Kai, Xiuchun Yu, Yong‐cheng Hu, et al.. (2020). Clinical Guideline for Microwave Ablation of Bone Tumors in Extremities. Orthopaedic Surgery. 12(4). 1036–1044. 18 indexed citations

Chen, Guojing, Zhen Wang, Ling Wang, et al.. (2018). A multicenter retrospective study of artificial joint replacement on giant cell tumor in distal femur. Zhonghua guke zazhi. 38(6). 338–345. 1 indexed citations

Ren, Ke, Jian Zhang, Xiaojie Gu, et al.. (2018). Migration-inducing gene-7 independently predicts poor prognosis of human osteosarcoma and is associated with vasculogenic mimicry. Experimental Cell Research. 369(1). 80–89. 16 indexed citations

Liu, Xiaozhou, Xing Zhou, Haidong Xu, et al.. (2017). SLC34A2 Regulates the Proliferation, Migration, and Invasion of Human Osteosarcoma Cells Through PTEN/PI3K/AKT Signaling. DNA and Cell Biology. 36(9). 775–780. 13 indexed citations

Lun, Dengxing, Yongcheng Hu, Zhen Wang, et al.. (2017). Development and proposal of a scoring system for giant cell tumour of the bone around the knee. International Orthopaedics. 42(1). 203–213. 5 indexed citations

Zheng, Kai, Xiuchun Yu, Yongcheng Hu, et al.. (2016). Surgical treatment for pelvic giant cell tumor: a multi-center study. World Journal of Surgical Oncology. 14(1). 104–104. 5 indexed citations

Li, Chengjun, et al.. (2016). Advances in Bone‐targeted Drug Delivery Systems for Neoadjuvant Chemotherapy for Osteosarcoma. Orthopaedic Surgery. 8(2). 105–110. 41 indexed citations

10.

Zhou, Xing, et al.. (2016). Expression of Matrix Metalloproteinase‐9 and CD34 in Giant Cell Tumor of Bone. Orthopaedic Surgery. 8(2). 220–225. 4 indexed citations

11.

Zheng, Kai, Zhen Wang, Sujia Wu, et al.. (2015). Giant Cell Tumor of the Pelvis: a Systematic Review. Orthopaedic Surgery. 7(2). 102–107. 14 indexed citations

12.

Shi, Xin, et al.. (2015). Focal adhesion kinase is involved in the migration of human osteosarcoma cells. Oncology Letters. 9(6). 2670–2674. 6 indexed citations

13.

Xiao, Xin, Wei Wang, Haoqiang Zhang, et al.. (2014). Individualized chemotherapy for osteosarcoma and identification of gene mutations in osteosarcoma. Tumor Biology. 36(4). 2427–2435. 15 indexed citations

14.

Liu, Xiaozhou, Sujia Wu, Xin Shi, et al.. (2014). Tumor-Suppressing Effects of miR-429 on Human Osteosarcoma. Cell Biochemistry and Biophysics. 70(1). 215–224. 27 indexed citations

15.

Zhi, Feng, Guangxin Zhou, Nan Shao, et al.. (2013). miR-106a-5p Inhibits the Proliferation and Migration of Astrocytoma Cells and Promotes Apoptosis by Targeting FASTK. PLoS ONE. 8(8). e72390–e72390. 63 indexed citations

16.

Yu, Xiuchun, et al.. (2013). Late post-operative recurrent osteosarcoma: Three case reports with a review of the literature. Oncology Letters. 6(1). 23–27. 8 indexed citations

17.

Shi, Xin, Yuxiu Liu, Chengjun Li, et al.. (2012). The preliminary report of a randomized controlled multicenter study of first-line chemotherapy regimen combined with angiogenesis inhibitor for osteosarcoma of the extremities. Zhonghua guke zazhi. 32(11). 1027–1031. 1 indexed citations

18.

Ren, Ke, et al.. (2012). Primary clavicle tumors and tumorous lesions: a review of 206 cases in East Asia. Archives of Orthopaedic and Trauma Surgery. 132(6). 883–889. 26 indexed citations

19.

Wu, Sujia, et al.. (2012). Composite Reconstruction of the Hip Following Resection of Periacetabular Tumors. The Journal of Arthroplasty. 28(3). 537–542. 6 indexed citations

20.

Wu, Sujia, et al.. (2010). Expression of matrix metalloproteinase regulator, RECK, and its clinical significance in osteosarcoma. Journal of Orthopaedic Research®. 28(12). 1621–1625. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact